Navigation Links
Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth,Conference and Attend Pacific Growth Equities Conference

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Metabasis Therapeutics (NASDAQ:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by targeting the liver and liver pathways, announced today that John Beck, senior vice president of finance and chief financial officer of Metabasis will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference at the Mandarin Oriental Hotel in New York, NY. Mr. Beck is scheduled to present on Wednesday, July 11, 2007 at 9:30 a.m. Eastern Time, and is expected to provide an overview of the Company's progress and discuss product candidates in clinical development. Metabasis will also be participating in the Pacific Growth Equities Cardiology & Metabolic Diseases Conference, scheduled for Thursday, July 12, 2007 at the Grand Hyatt Hotel in New York, NY.

To access the live audio broadcast and the subsequent archived audio recording of the presentation, please log onto the Company's website at www.mbasis.com under the "Investors" section. The audio recording and presentation will be archived there for 30 days following the live presentation. Please connect to Metabasis' website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary.

About Metabasis (www.mbasis.com):

Metabasis Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs to address some of the world's most widespread and costly chronic diseases involving pathways in the liver. The Company has established a pipeline that includes clinical stage and preclinical product candidates targeting major diseases with significant unmet medical needs. Targeted diseases include major metabolic diseases such as diabetes, hyperlipidemia and obesity as well as liver dise
'"/>




Page: 1 2

Related medicine technology :

1. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
2. Metabasis Therapeutics to Present Poster at American Association for Cancer Research
3. The Past, Present and Future of HLA Typing
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
Post Your Comments:
(Date:12/20/2013)... 2013 Editor Note: For more ... Today, Analysts, Corner announced new research reports highlighting Dyax ... Inc. (NASDAQ: IPCM ), Array BioPharma Inc. (NASDAQ: ... LXRX ), and Wright Medical Group, Inc. (NASDAQ: WMGI). Today,s ... full price targets, industry analysis and analyst ratings - via ...
(Date:12/20/2013)... YORK , December 20, 2013 ... (NYSE: PRGO ), Thermo Fisher Scientific, Inc. (NYSE: ... ), United Therapeutics Corporation (NASDAQ: UTHR ), and ... reports free of charge - including full price targets, industry ... Perrigo Co. Research Report On December 17, ...
(Date:12/20/2013)... JERUSALEM , Dec. 20, 2013 ... a clinical-stage pharmaceutical company focused on the development ... results in a clinical trial testing the pharmacokinetic ... in type 1 diabetes patients.  ... oral insulin at each study visit; blood glucose ...
Breaking Medicine Technology:Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical 2Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical 3Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical 4Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical 5Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical 6Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 2Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 3Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 4Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 5Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes 2Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes 3Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes 4
(Date:12/21/2013)... Dallas,TX (PRWEB) December 21, 2013 ... lifestyles in the baby boomer generation, but it's elements ... 50 Lists are topics, services, and products chosen by ... the various audiences the magazine reaches out to and ... List reflects the staffs choice for the best health ...
(Date:12/21/2013)... NY (PRWEB) December 21, 2013 Hacking the ... a major coup in the hacker world. Successfully targeting ... furious shopping days of the year, that’s like hitting the ... and really big money. On the heels of Target’s ... information of up to 40 million customers shopping at its ...
(Date:12/21/2013)... Register for the webinar playback: http://bit.ly/1fvzVjj ... a panel of leading experts to explore current trends ... panel makes recommendations on modifying deal approach and deal ... cross-border transactions. Register here for the webinar playback. ... secure virtual data room (VDR) solution that optimises the ...
(Date:12/21/2013)... This week, Bioforce USA launched Phase 1 of ... the site is in keeping with the company’s business ... consumers to make informed choices. Phase II of the ... , Company President and CEO, Pierce Sioussat states: “As ... we were able to achieve with this new platform. Our ...
(Date:12/21/2013)... December 21, 2013 Today, AD Surgical ... disposable sterile drapes to its growing portfolio of ... cover the broadest range of surgical procedures for simple ... an absorbent and completely impervious PE/PP non-woven material to ... Each drape also has a peel-able adhesive tape and ...
Breaking Medicine News(10 mins):Health News:Esteemed Living Top 50 List ranks Top Health Bloggers in America 2Health News:Bah Humbug! Hack on Target Could Scrooge-Over 40 Million Holiday Shoppers 2Health News:Bah Humbug! Hack on Target Could Scrooge-Over 40 Million Holiday Shoppers 3Health News:Bah Humbug! Hack on Target Could Scrooge-Over 40 Million Holiday Shoppers 4Health News:Bah Humbug! Hack on Target Could Scrooge-Over 40 Million Holiday Shoppers 5Health News:Bah Humbug! Hack on Target Could Scrooge-Over 40 Million Holiday Shoppers 6Health News:Register for Merrill DataSite's Webinar Playback: Best Practices for Strategic Growth: Where to Invest in the Maturing U.S. Economy 2Health News:AD Surgical Introduces a New Line of Universal Sterile Drapes 2
... days on mechanical ventilation another drawback for sedated patients, ... Critically ill patients in intensive care who aren,t sedated ... time in the intensive care unit than those who ... included 113 critically ill adult patients expected to need ...
... The American Association of Physicists in Medicine (AAPM) has issued ... in the New York Times yesterday and earlier in the ... in the last decade involving people undergoing radiation therapy. ... these events, the statement acknowledges their gravity. It reads in ...
... , NASHVILLE, Tenn. , Jan. 29 ... fourth quarter and fiscal year ended December 31, 2009 ... the Company,s year-end financial and accounting procedures. , (Logo: ... in these uncertain economic times," said Richard M. Bracken ...
... , , LAS VEGAS , ... tie!  Here are the top five gifts for Valentine,s Day ...   , (Photo:   http://www.newscom.com/cgi-bin/prnh/20100129/SF46111 ) , 5. Edible Passion ... The Main Course   , Use the feather tickler to ...
... ... of those with Mental Health Problems Looks to Interactive Agency for Website Support , ... St. Louis, MO (PRWEB) January 29, ... firm, proudly announces their partnership with the Karla Smith Foundation (KSF), an organization focused on ...
... ... the medical journal Osteoporosis International found that women taking AdvaCAL® calcium had the highest ... The 32 studies involved 3,169 postmenopausal women, 79 skeletal measures and 7 different types ... ...
Cached Medicine News:Health News:Sedation Linked to Longer Stay in ICU 2Health News:AAPM statement on quality radiation therapy 2Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 2Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 3Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 4Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 5Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 6Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 7Health News:HCA Previews Fourth Quarter and Year-End 2009 Results 8Health News:The Five Best Valentine's Day Gifts You've Never Heard of - Starting Under $20 2Health News:The Five Best Valentine's Day Gifts You've Never Heard of - Starting Under $20 3Health News:The Five Best Valentine's Day Gifts You've Never Heard of - Starting Under $20 4Health News:The Net Impact is Proud to Announce Partnership with the Karla Smith Foundation 2Health News:The Net Impact is Proud to Announce Partnership with the Karla Smith Foundation 3Health News:The Net Impact is Proud to Announce Partnership with the Karla Smith Foundation 4Health News:Report: AdvaCALCalcium Builds Bone Best 2
Exceptional illumination and realiability from this small source....
The 81130 Xenon AC/DC light source is the brightest, smallest transportable unit avaliable. The quck charge rechargable battery and low power consumption allows for 2 hours continuous use in the fie...
Tested by surgeons for functionality and ergonomy. Uses the Medifix C3-3001-3CCD camera head....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 625 lines, NTSC output at 525 lines. 23mm focal length. Output via Y/C mini-DIN-4 port. 135mm length x 44mm ...
Medicine Products: